Aura Biosciences (AURA) IPO Opens Flat

Today’s IPO for Aura Biosciences, Inc. (NASDAQ: AURA) opened for trading at $14.10 after pricing 5,400,000 shares of common stock at a public offering price of $14.00 per share.

Cowen, SVB Leerink and Evercore ISI are acting as joint book-running managers for the offering, and BTIG is acting as lead manager for the offering.

Aura Biosciences, Inc. is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates (VDCs) to target and destroy cancer cells selectively while activating the immune system to create long lasting anti-tumor immunity.

You May Also Be Interested In

• Karman Line Acquisition closes $200M IPO on Nasdaq
• NorthStrive Acquisition prices $100M IPO on Nasdaq
• Anthropic wants to match or beat SpaceX’s record IPO size - report